PMID: 9551494Apr 29, 1998Paper

Neurodevelopmental and neuroprogressive processes in schizophrenia. Antithetical or complementary, over a lifetime trajectory of disease?

The Psychiatric Clinics of North America
J L WaddingtonE O'Callaghan

Abstract

The neurodevelopmental model of schizophrenia maintains ascendancy among current etiopathologic perspectives on schizophrenia. However, inconsistencies across studies and the absence thus far of pathognomic brain changes suggest the need for complex conceptualization of neurodevelopmental arrest, including some reconciliation with the competing neurodegenerative model of schizophrenia. This article critically reviews the preponderance of evidence for each model and provides an account of how these may interact or synergize to produce the characteristic clinical expression of schizophrenia.

References

Sep 1, 1992·Psychiatry Research·J A HustedW G Iacono
Sep 1, 1992·The American Journal of Psychiatry·A D LoebelS R Szymanski
Oct 1, 1992·The American Journal of Psychiatry·H S BrachaC Cunniff
Feb 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleR S Frackowiak
Mar 1, 1992·Archives of General Psychiatry·R B ZipurskyA Pfefferbaum
Mar 1, 1992·The Cleft Palate-craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association·G H Sperber
Jan 1, 1991·Schizophrenia Bulletin·R J Wyatt
Nov 1, 1991·Early Human Development·J Mojsilović, N Zecević
Mar 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·R Goodman
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·T J CrowE C Johnstone
Oct 17, 1987·British Medical Journal·J L Waddington, H A Youssef
Jan 1, 1987·American Journal of Medical Genetics. Supplement·M S Lubinsky
Jul 1, 1988·AJR. American Journal of Roentgenology·A J Barkovich, D Norman
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Aug 26, 1995·Lancet·D R Weinberger
Jul 31, 1995·American Journal of Medical Genetics·M G ButlerS B Cassidy
Jun 19, 1995·American Journal of Medical Genetics·A E PulverH Chen
Aug 1, 1995·Schizophrenia Research·W G HonerG Gewirtz
Sep 9, 1995·Lancet·P McGuffinA E Farmer
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·D BarbeauL K Srivastava
Jan 1, 1995·Brain Research. Brain Research Reviews·A Parent, L N Hazrati
Feb 1, 1995·Nature Genetics·J J Mulvihill
Feb 1, 1995·The American Journal of Psychiatry·M DavidsonE Frecska
Mar 10, 1995·Science·H Steller
Mar 1, 1994·The Cleft Palate-craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association·G H Sperber, G A Machin
Nov 1, 1994·The Journal of Nervous and Mental Disease·R C AlexanderC A Kaufmann
Apr 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·T M HydeJ E Kleinman
Aug 1, 1994·The Journal of Nervous and Mental Disease·A E PulverD Housman

❮ Previous
Next ❯

Citations

Apr 21, 1999·Brain Research. Brain Research Reviews·G E DuncanJ A Lieberman
Jan 30, 2002·Psychiatry Research·H J ChiuS J Tsai
Aug 19, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shuji IritaniPiers C Emson
Apr 14, 2000·Psychiatry Research·S GalderisiG Invernizzi
Nov 24, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·J McClellanA DuBose
Jul 2, 2005·Journal of Psychiatric Practice·J L WaddingtonM G Morgan
Oct 9, 2013·The International Journal of Neuropsychopharmacology·Herbert Y MeltzerMasakuni Horiguchi
Jul 26, 2005·Neuroscience Letters·Xingqun NiJames L Kennedy
Jun 22, 2006·Neurotoxicology·G Jean HarrySusan H Brunssen
Jul 27, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Yanbo ZhangDai Zhang
Dec 24, 2002·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Kenji NakataShigetoshi Kuroda
Aug 18, 2012·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Marwan Sheikh-TahaAbeer Zeitoun
Apr 8, 2011·Expert Review of Neurotherapeutics·Gary RemingtonGeorge Foussias

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.